INVO News and Press, INVO BioScience Inc. From 05/09/22

INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , May 9, 2022 /PRNewswire/ -...

INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia PR Newswire Bloom Fertility, an INVO Center to grant three eligible patients a full IVC treatment cycle SARASOTA, Fla. , April 28, 2022 /PRNewswire/ -- ...

Gainers: Vallon Pharmaceuticals (VLON) +84%. Shattuck Labs (STTK) +12%. Establishment Labs (ESTA) +11%. INVO Bioscience (INVO) +5%. Novan (NOVN) +5%. Losers: Babylon Holdings (BBLN) -41%. SCYNEXIS (SCYX) -25%. Clarus Therapeutics (CRXT) -16%. HCA H...

INVO Selects Kansas City as additional INVO Center Location PR Newswire U.S. Market Expansion Continues as Planned SARASOTA, Fla. , April 14, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO) ("INVO" or the "Company"), a commercial-sta...

INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference PR Newswire SARASOTA, Fla. , April 4, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to adva...

INVO Bioscience, Inc. (INVO) Q4 2021 Earnings Conference Call March 31, 2022, 4:30 PM ET Company Participants Steven Shum – Chief Executive Officer Andrea Goren – Chief Financial Officer Michael Campbell – Chief Operating Officer and Vice President, Business Development R...

INVO BioScience press release (NASDAQ:INVO): FY GAAP EPS of -$0.63 beats by $0.24. Revenue of $4.16M (+300.0% Y/Y) beats by $2.84M. For further details see: INVO BioScience GAAP EPS of -$0.63 beats by $0.24, revenue of $4.16M beats by $2.84M

INVO Bioscience Reports 2021 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET ; Slide Presentation Also Available SARASOTA, Fla. , March 31, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" ...

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , March 24,...

INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting PR Newswire SARASOTA, Fla. , March 24, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell ® , an advanced f...